Development platform
Regulatory catalogue · RI-US-013 · United States

Container and carton design guidance

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors (guidance for industry)

G1Official guidanceIn forceArtwork impact: high

Summary

FDA's design principles for container labels and carton labeling: what goes on the principal display panel, how to express strength, use of colour, typography, and how to avoid clutter and confusion between products.

More in the full catalogue Key labelling requirements (4), transition and timeline notes, related documents and CSV export are available to testers. Sign in · Register

Relevance by packaging component

ComponentRelevanceWhat it concerns
CartonOuter packaging / folding carton D Direct
LabelImmediate container label (bottle, tube, large vial, bag) D Direct
Blister / foilBlisters, strips, sachets, lidding foil I Indirect
Small unitSmall immediate packaging: ampoule, small vial, cartridge, pen D Direct
LeafletPackage leaflet / PIL, package insert, prescribing information, Medication Guide –
DeviceIntegral or co-packaged device and its instructions for use –
Shipper / caseTertiary packaging: shipping case, homogeneous case, pallet –
e-LabellingElectronic product information, QR / 2D-code linked content –

packart.dev summary, not a quotation of the source. Confirm requirements in the official text before regulatory use.